APP and Alzheimer disease: These aberrant neuronal activity and/or seizure modulate cognitive deficits in amyloid precursor protein (APP) transgenic mice and patients with amnestic mild cognitive impairment [6, 9-12], and may directly contribute to cognitive deficits early in AD progression [13].